Literature DB >> 9071939

Altered expression of alpha 4 beta 7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation.

J Meenan1, J Spaans, T A Grool, S T Pals, G N Tytgat, S J van Deventer.   

Abstract

BACKGROUND AND AIMS: Expression of alpha 4 beta 7 on memory T lymphocytes identifies a cell population that preferentially migrates to the gut. Detection of alpha 4 beta 7 on circulating lymphocytes may permit the identification of specific subsets trafficking between the circulation and the gut in inflammatory bowel diseases. PATIENTS: Samples and clinical details were taken from patients with Crohn's disease (CD), ulcerative colitis (UC), diverticulitis/ infectious colitis, and healthy controls.
METHODS: Peripheral blood and lamina propria mononuclear cells were isolated. Cells were labelled with CD3, CD4, CD25, CD45RO or alpha 4 beta 7.
RESULTS: Median levels of circulating total memory T cells (CD4+CD45RO+) were increased in CD (p < 0.01) and UC (p < 0.05). However, the proportion of systemic gut homing T cells (CD4+CD45RO+ alpha 4 beta 7+) was decreased in CD (p < 0.05), UC (p < 0.002), and inflammatory controls (p < 0.05). Levels of activated gut homing T cells (CD4+CD25+ alpha 4 beta 7+) were increased in CD (p < 0.01) and UC (p < 0.05). For both CD4+CD45RO+ and CD4+CD25+ cells, the proportion of lymphocytes coexpressing alpha 4 beta 7 was decreased compared with controls. In small and large intestine lamina propria, expression of alpha 4 beta 7+ on CD3+ cells was extensive, although it was decreased in CD (p < 0.03), UC (p < 0.05), and inflammatory controls (p < 0.05).
CONCLUSIONS: Circulating and mucosal gut homing lymphocyte populations are changed in patients with colonic inflammation. This may arise due to a dilution effect from recruited naive T cells, or from integrin down regulation. Changes in general CD4+ lymphocyte populations mask more subtle variations in those cells with gut homing potential.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9071939      PMCID: PMC1027056          DOI: 10.1136/gut.40.2.241

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  40 in total

Review 1.  Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.

Authors:  T A Springer
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

2.  Comparison of lymphokine secretion and mRNA expression in the CD45RA+ and CD45RO+ subsets of human peripheral blood CD4+ and CD8+ lymphocytes.

Authors:  K Conlon; J Osborne; C Morimoto; J R Ortaldo; H A Young
Journal:  Eur J Immunol       Date:  1995-03       Impact factor: 5.532

3.  Expression of the mucosal homing receptor alpha 4 beta 7 in malignant lymphomatous polyposis of the intestine.

Authors:  S T Pals; P Drillenburg; B Dragosics; A I Lazarovits; T Radaszkiewicz
Journal:  Gastroenterology       Date:  1994-11       Impact factor: 22.682

4.  Membrane CD45R isoform exchange on CD4 T cells is rapid, frequent and dynamic in vivo.

Authors:  S M Sparshott; E B Bell
Journal:  Eur J Immunol       Date:  1994-11       Impact factor: 5.532

Review 5.  Aetiology and pathogenesis of chronic inflammatory bowel disease.

Authors:  T T MacDonald; S H Murch
Journal:  Baillieres Clin Gastroenterol       Date:  1994-03

6.  Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.

Authors:  B Sadlack; H Merz; H Schorle; A Schimpl; A C Feller; I Horak
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

7.  Short-term course and prognosis of Crohn's disease.

Authors:  F T De Dombal; I L Burton; S E Clamp; J C Goligher
Journal:  Gut       Date:  1974-06       Impact factor: 23.059

8.  Expression and function of the MAdCAM-1 receptor, integrin alpha 4 beta 7, on human leukocytes.

Authors:  D J Erle; M J Briskin; E C Butcher; A Garcia-Pardo; A I Lazarovits; M Tidswell
Journal:  J Immunol       Date:  1994-07-15       Impact factor: 5.422

9.  Gut-homing CD4+ T cell receptor alpha beta+ T cells in the pathogenesis of murine inflammatory bowel disease.

Authors:  A Rudolphi; G Boll; S S Poulsen; M H Claesson; J Reimann
Journal:  Eur J Immunol       Date:  1994-11       Impact factor: 5.532

10.  Crohn's disease, ulcerative colitis, and normal intestinal lymphocytes express integrins in dissimilar patterns.

Authors:  B R Yacyshyn; A Lazarovits; V Tsai; K Matejko
Journal:  Gastroenterology       Date:  1994-11       Impact factor: 22.682

View more
  31 in total

Review 1.  Preclinical and clinical pharmacology of antisense oligonucleotides.

Authors:  E G Marcusson; B R Yacyshyn; W R Shanahan; N M Dean
Journal:  Mol Biotechnol       Date:  1999-08       Impact factor: 2.695

2.  Quantitative and functional characteristics of intestinal-homing memory T cells: analysis of Crohn's disease patients and healthy controls.

Authors:  A L Hart; M A Kamm; S C Knight; A J Stagg
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

3.  CCR4 is an up-regulated chemokine receptor of peripheral blood memory CD4+ T cells in Crohn's disease.

Authors:  Y Jo; T Matsumoto; S Yada; K Fujisawa; M Esaki; N Onai; K Matsushima; M Iida
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

4.  Active Crohn's disease patients show a distinctive expansion of circulating memory CD4+CD45RO+CD28null T cells.

Authors:  Jaime García de Tena; Luis Manzano; Juan Carlos Leal; Esther San Antonio; Verónica Sualdea; Melchor Alvarez-Mon
Journal:  J Clin Immunol       Date:  2004-03       Impact factor: 8.317

5.  Impaired mitogenic response of peripheral blood T cells in ulcerative colitis is not due to apoptosis.

Authors:  M A Pérez-Machado; L M Espinosa; E J de la Madrigal; L Abreu; G M Lorente; M Alvarez-Mon
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

6.  Appendix is a priming site in the development of ulcerative colitis.

Authors:  Mitsunobu Matsushita; Hiroshi Takakuwa; Yuji Matsubayashi; Akiyoshi Nishio; Susumu Ikehara; Kazuichi Okazaki
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

Review 7.  Meta-analysis of the effectiveness and safety of vedolizumab for ulcerative colitis.

Authors:  Yu Jin; Yan Lin; Lian-Jie Lin; Chang-Qing Zheng
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

Review 8.  Biological therapy for ulcerative colitis: an update.

Authors:  Geom Seog Seo; Soo-Cheon Chae
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

Review 9.  Novel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion molecules.

Authors:  Kazuhiko Nakamura; Kuniomi Honda; Takahiro Mizutani; Hirotada Akiho; Naohiko Harada
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

10.  Increase in podoplanin-expressing intestinal lymphatic vessels in inflammatory bowel disease.

Authors:  Silvana Geleff; Sebastian F Schoppmann; Georg Oberhuber
Journal:  Virchows Arch       Date:  2003-01-16       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.